2019 Travel Vaccines Market | Global Industry Report, Growth, Opportunities and Forecast till 2024

by IVO Smith Business Analyst

According to the latest report by IMARC Group, the travel vaccines market size reached US$ 4.9 Billion in 2018. Travel vaccines are immunization shots that travelers can get before traveling to other parts of the world where there is a high risk of developing certain diseases. These vaccines build immunity against viral and microbial invasions while improving the overall health of the individual. They introduce the disease-causing microbes into the bloodstream to help the human body develop antibodies to fight off the same, if exposed to in the future. These shots must be taken at least 4 to 6 weeks before traveling as this gives enough time for the immunization to start working efficiently.

Global Travel Vaccines Market Trends:

Rising occurrence of infectious and travel-related diseases such as Japanese encephalitis, diphtheria, meningitis and yellow fever is one of the major factors that are driving the growth of the market. In addition to this, owing to factors such as the rising globalization and reduced international airfares, there has been an increase in international tourism. Consequently, the sales of travel vaccines have also witnessed a significant rise across the globe. Apart from this, several combination vaccines are also available for travelers, which protect against more than one disease. They are widely gaining popularity amongst the users as they reduce the number of vaccines required. Furthermore, government bodies in several countries are investing in promoting the use of these vaccines. For instance, the National Health Service (NHS) is providing several free travel vaccines for diseases such as cholera, polio, typhoid and hepatitis A in the United Kingdom to reduce the risk of these diseases being spread across the country. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 8.1 billion by 2024, growing at a CAGR of around 9% during 2019-2024.

Market Segmentation

Market Breakup by Composition

1. Mono Vaccines

2. Combination Vaccines

Market Breakup by Disease

1. Hepatitis A

2. DPT

3. Yellow Fever

4. Typhoid

5. Hepatitis B

6. Measles and Mumps

7. Rabies

8. Meningococcal

9. Varicella

10. Japanese Encepthalitis

11. Others

Market Breakup by Region

1. North America

2. Europe

3. Asia Pacific

4. Middle East and Africa

5. Latin America

Request For Free Sample Pdf Copy @

Some of the major players operating in the industry include

Novartis AG ADR (NVS)

GlaxoSmithKline plc (GSK)

Sanofi S.A. (SAN)

Merck & Co. Inc. (MRK)

Pfizer (NYSE: PFE)


Bavarian Nordic

Crucell N.V.

CSL Limited

MedImmune, LLC,


Abbott Laboratories

F. Hoffman-La Roche Ltd.

Contact US: IMARC Group
309 2nd St, Brooklyn, NY 11215, USA
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

Sponsor Ads

About IVO Smith Innovator   Business Analyst

16 connections, 1 recommendations, 69 honor points.
Joined APSense since, April 18th, 2019, From Brooklyn, United States.

Created on Jan 6th 2020 04:23. Viewed 166 times.


No comment, be the first to comment.
Please sign in before you comment.